Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1

Objective: This study sought to determine the mean prognostic usefulness of seleniumphosphate synthase ( SEPHS1 ) by investigating its expression in 33 human malignancies and its relationship to tumor immunity. Methods: The expression of selenophosphate synthase 1 ( SEPHS1 ) in 33 human malignant tu...

Full description

Bibliographic Details
Main Authors: Jie Hao, Ao-Yue He, Xu Zhao, Xue-Qin Chen, Qi-Ling Liu, Na Sun, Rong-Qiang Zhang, Ping-Ping Li
Format: Article
Language:English
Published: SAGE Publishing 2023-04-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748231170485
_version_ 1797688164905648128
author Jie Hao
Ao-Yue He
Xu Zhao
Xue-Qin Chen
Qi-Ling Liu
Na Sun
Rong-Qiang Zhang
Ping-Ping Li
author_facet Jie Hao
Ao-Yue He
Xu Zhao
Xue-Qin Chen
Qi-Ling Liu
Na Sun
Rong-Qiang Zhang
Ping-Ping Li
author_sort Jie Hao
collection DOAJ
description Objective: This study sought to determine the mean prognostic usefulness of seleniumphosphate synthase ( SEPHS1 ) by investigating its expression in 33 human malignancies and its relationship to tumor immunity. Methods: The expression of selenophosphate synthase 1 ( SEPHS1 ) in 33 human malignant tumors was examined using the Genotype-Tissue Expression (GTEx), Cancer Genome Atlas (TCGA), and TIMER databases. Furthermore, the TCGA cohort was used to investigate relationships between SEPHS1 and immunological checkpoint genes (ICGs), tumor mutation burden (TMB), microsatellite instability (MSI), and DNA mismatch repair genes (MMRs). To establish independent risk factors and calculate survival probabilities for liver hepatocellular carcinoma (LIHC) and brain lower-grade glioma (LGG), Cox regression models and Kaplan-Meier curves were utilized. Eventually, the Genomics of Cancer Drug Sensitivity (GDSC) database was used to evaluate the drug sensitivity in LGG and LIHC patients with high SEPHS1 expression. Results: Overall, in numerous tumor tissues, SEPHS1 was highly expressed, and it significantly linked with the prognosis of LGG, ACC, and LIHC ( P < .05). Furthermore, in numerous cancers, SEPHS1 expression was linked to tumor-infiltrating immune cells (TIICs), TMB, MSI, and MMRs. According to univariate and multivariate Cox analyses, SEPHS1 expression was significant for patients with LGG and LIHC. Conclusion: High SEPHS1 expression has a better prognosis for LGG, while low SEPHS1 expression has a better prognosis for LIHC. Chemotherapy was advised for LGG patients, particularly for those with high SEPHS1 expression because it can predict how responsive patients will be to 5-Fluorouracil and Temozolomide. This interaction between SEPHS1 and chemoradiotherapy has a positive clinical impact and may be used as evidence for chemotherapy for LGG and LIHC patients.
first_indexed 2024-03-12T01:27:19Z
format Article
id doaj.art-7676c75b69db422fa9bbdf2bb58f4acd
institution Directory Open Access Journal
issn 1526-2359
language English
last_indexed 2024-03-12T01:27:19Z
publishDate 2023-04-01
publisher SAGE Publishing
record_format Article
series Cancer Control
spelling doaj.art-7676c75b69db422fa9bbdf2bb58f4acd2023-09-12T14:03:34ZengSAGE PublishingCancer Control1526-23592023-04-013010.1177/10732748231170485Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1Jie HaoAo-Yue HeXu ZhaoXue-Qin ChenQi-Ling LiuNa SunRong-Qiang ZhangPing-Ping LiObjective: This study sought to determine the mean prognostic usefulness of seleniumphosphate synthase ( SEPHS1 ) by investigating its expression in 33 human malignancies and its relationship to tumor immunity. Methods: The expression of selenophosphate synthase 1 ( SEPHS1 ) in 33 human malignant tumors was examined using the Genotype-Tissue Expression (GTEx), Cancer Genome Atlas (TCGA), and TIMER databases. Furthermore, the TCGA cohort was used to investigate relationships between SEPHS1 and immunological checkpoint genes (ICGs), tumor mutation burden (TMB), microsatellite instability (MSI), and DNA mismatch repair genes (MMRs). To establish independent risk factors and calculate survival probabilities for liver hepatocellular carcinoma (LIHC) and brain lower-grade glioma (LGG), Cox regression models and Kaplan-Meier curves were utilized. Eventually, the Genomics of Cancer Drug Sensitivity (GDSC) database was used to evaluate the drug sensitivity in LGG and LIHC patients with high SEPHS1 expression. Results: Overall, in numerous tumor tissues, SEPHS1 was highly expressed, and it significantly linked with the prognosis of LGG, ACC, and LIHC ( P < .05). Furthermore, in numerous cancers, SEPHS1 expression was linked to tumor-infiltrating immune cells (TIICs), TMB, MSI, and MMRs. According to univariate and multivariate Cox analyses, SEPHS1 expression was significant for patients with LGG and LIHC. Conclusion: High SEPHS1 expression has a better prognosis for LGG, while low SEPHS1 expression has a better prognosis for LIHC. Chemotherapy was advised for LGG patients, particularly for those with high SEPHS1 expression because it can predict how responsive patients will be to 5-Fluorouracil and Temozolomide. This interaction between SEPHS1 and chemoradiotherapy has a positive clinical impact and may be used as evidence for chemotherapy for LGG and LIHC patients.https://doi.org/10.1177/10732748231170485
spellingShingle Jie Hao
Ao-Yue He
Xu Zhao
Xue-Qin Chen
Qi-Ling Liu
Na Sun
Rong-Qiang Zhang
Ping-Ping Li
Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1
Cancer Control
title Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1
title_full Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1
title_fullStr Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1
title_full_unstemmed Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1
title_short Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1
title_sort pan cancer study of the prognosistic value of selenium phosphate synthase 1
url https://doi.org/10.1177/10732748231170485
work_keys_str_mv AT jiehao pancancerstudyoftheprognosisticvalueofseleniumphosphatesynthase1
AT aoyuehe pancancerstudyoftheprognosisticvalueofseleniumphosphatesynthase1
AT xuzhao pancancerstudyoftheprognosisticvalueofseleniumphosphatesynthase1
AT xueqinchen pancancerstudyoftheprognosisticvalueofseleniumphosphatesynthase1
AT qilingliu pancancerstudyoftheprognosisticvalueofseleniumphosphatesynthase1
AT nasun pancancerstudyoftheprognosisticvalueofseleniumphosphatesynthase1
AT rongqiangzhang pancancerstudyoftheprognosisticvalueofseleniumphosphatesynthase1
AT pingpingli pancancerstudyoftheprognosisticvalueofseleniumphosphatesynthase1